Effect of Modified Poco-Poco Exercise to Frailty Stages, Expression of Global DNA Methylation, GDF15 and Lamin A COP

ConditionFrail Elderly
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorUniversitas Padjadjaran

About this trial

The goal of this clinical trial is to know the effect of multicomponent exercise in frail elderly in community to aging hallmarks. The main question\[s\] it aims to answer are:

1. Do global DNA methylation levels change in elderly people in Bandung after receiving modified poco-poco exercise? 2. Do GDF15 levels change in elderly people in Bandung after they are given modified poco-poco exercise? 3. Do lamin A COP levels change in elderly people in Bandung after they are given modified poco-poco exercise? 4. Does the level of frailty in elderly people in Bandung change after they are given modified poco-poco exercise?

Participants will be asked to do flexibility, balance, aerobic and strengthening exercise included in poco-poco modified exercise three times a week for 12 weeks

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Frailty level is in pre-frailty

MoCA INA score above 18

Domicile in Bandung City

Willing to participate in the study after informed consent

Disqualifiers

There is a hearing impairment that may prevent the subject from receiving verbal instructions

There is uncorrected visual impairment

There are musculoskeletal disorders so that they cannot perform exercise procedures or procedures for measuring research variables

Subjects received other rehabilitation programs

Trial design

Design model

Single group

Treatments tested in this trial

  • EXERCISE TRAINING WITH OR WITHOUT MEDICATION

    Other intervention

    Exercise training that consists of flexibility, aerobic, balance and strengthening regime. The exercise given three times a week, for 12 weeks.

Treatment groups

17 Participants
are divided into 1 treatment group
Group A: Frail elderly living in communityExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Change From Baseline in Level of Global DNA Methylation in 12 Weeks

Global DNA Methylation will be measured twice using ...

Time frame
week 0 and week 12
2

Change From Baseline in Level of Growth Deficiency Factor (GDF15) in 12 Weeks

GDF15 will be measured using blood plasma with Enzyme Linked Immuno Assay (ELISA), expected GDF value that show improvement that it will be decreased

Time frame
week 0 and week 12
3

Change From Baseline in Level of Lamin A (Cyclic Osteo Progenitor) COP in 12 Weeks

Lamin A COP will be measured with flow cytometry from Peripheral Blood Mononuclear Cells (PBMC), the value that shows improvement has a lesser lamin A COP population

Time frame
week 0 and week 12
4

Change From Baseline in Level of Frailty in 12 Weeks

Level of Frailty is measured using Fried's Frailty Phenotype with range 1-5 with 5 is the worst level of frailty. Fried's frailty measured with five components that are unintentional weight loss, muscle weakness, exhaustion on activity, slow gait and low physical activity.

Time frame
week 0 and week 12

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.